4.1 Article Data Paper

A reconstructed melanoma data set for evaluating differential treatment benefit according to biomarker subgroups

期刊

DATA IN BRIEF
卷 12, 期 -, 页码 667-675

出版社

ELSEVIER
DOI: 10.1016/j.dib.2017.05.005

关键词

-

资金

  1. National Cancer Institute, USA [R01 CA137420, R01 CA197402, P30 CA008748]
  2. Clinical and Translational Science Center at Weill Cornell Medical College, NewYork, USA [UL1RR024996]

向作者/读者索取更多资源

The data presented in this article are related to the research article entitled Measuring differential treatment benefit across marker specific subgroups: the choice of outcome scale (Satagopan and lasonos, 2015) [1]. These data were digitally reconstructed from figures published in Larkin et al. (2015) [2]. This article describes the steps to digitally reconstruct patient-level data on time-to-event outcome and treatment and biomarker groups using published Kaplan-Meier survival curves. The reconstructed data set and the corresponding computer programs are made publicly available to enable further statistical methodology research. (C) 2017 The Authors. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据